About AMNEPARA-IV(PARACETAMOL I.P)
Capitalise on the outstanding efficacy of AMNEPARA-IV (PARACETAMOL I.P), a special, dominant analgesic and antipyretic available in a 100 ml sterile, non-pyrogenic bottle. With an excellent 1000mg/100ml strength, this product is offered in limited stock-ideal for hospitals requiring proven solutions for fever and mild to moderate pain, including postoperative scenarios. Designed for single-dose intravenous use only, AMNEPARA-IV delivers reliable relief. Offered via PCD Pharma Franchise, this Rx-only clear solution supports both adults and children as directed by a physician. Secure your supply now and ensure excellent patient care.
AMNEPARA-IV: Application & Areas of Use
AMNEPARA-IV (PARACETAMOL I.P) is administered exclusively by intravenous infusion, ensuring rapid and reliable effect. Used primarily for fever reduction and management of mild to moderate or postoperative pain, its application is limited to hospital settings where professional monitoring is available. The infusion solution is intended for direct administration into the vein, guaranteeing consistent dosage and swift therapeutic action across the indicated surfaces of application, making it suitable for both adults and children as advised.
Supply, Market Reach & Packaging Details for AMNEPARA-IV
With a focus on prompt order processing and secure packaging, AMNEPARA-IV is designed for efficient distribution across the main domestic markets in India. Product delivery is streamlined through the designated FOB port, ensuring minimal charge and timely arrival. Each 100 ml single-dose bottle comes in specialized packaging to preserve sterility and product integrity, supporting a robust supply chain for medical facilities and pharmacies seeking reliable stock in limited quantities.
FAQ's of AMNEPARA-IV(PARACETAMOL I.P):
Q: How should AMNEPARA-IV (PARACETAMOL I.P) be administered?
A: AMNEPARA-IV should be administered only as an intravenous infusion by healthcare professionals, following the prescribed dosage and guidelines set by a physician.
Q: What primary conditions does AMNEPARA-IV treat?
A: AMNEPARA-IV is specifically formulated for the management of fever, mild to moderate pain, and postoperative pain in a hospital environment.
Q: When is it advisable to use AMNEPARA-IV over oral paracetamol options?
A: AMNEPARA-IV is recommended when rapid onset of action is needed, or when oral administration is not possible, such as post-surgery or in patients unable to swallow.
Q: Where is the product most commonly used?
A: This product is dominant in hospital settings, where controlled, sterile, intravenous analgesic and antipyretic administration is required for patient care.
Q: What are the storage requirements for AMNEPARA-IV?
A: AMNEPARA-IV should be stored below 25C and protected from light to maintain its sterility and effectiveness.
Q: What are the franchise options for AMNEPARA-IV?
A: AMNEPARA-IV is available through PCD Pharma Franchise options, enabling suppliers and traders in India to capitalise on distribution opportunities.